Endo Pharmaceuticals Holdings Inc. Condensed Consolidated Cash Flow Data (unaudited) (in thousands) | |||
Six Months EndedJune 30, | |||
2010 | 2009 | ||
| Net cash provided by operating activities | $ 176,356 | $ 140,572 | |
| Net cash provided by (used in) investing activities | 154,785 | (424,758) | |
| Net cash (used in) provided by financing activities | (47,332) | 3,482 | |
| Net increase (decrease) in cash and cash equivalents | $ 283,809 | $ (280,704) | |
| Cash and cash equivalents, beginning of period | $ 708,462 | $ 775,693 | |
| Cash and cash equivalents, end of period | $ 992,271 | $ 494,989 | |
